FDA Investigator

Dipesh K Shah

Latest inspection on record: Linhai, China, April 2026 · records back to 2008

Human DrugsMedical Devices & Rad HealthFoods & CosmeticsAnimal Drugs & FeedsBiologics

FDA inspection record · Last updated July 12, 2026

Overview

  • 204 inspections across 190 sites are on record.
  • 368 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-04-24.

At a glance

Inspections

204

Sites

190

Observations

368

Career since

Feb 2008

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Zhejiang Huahai Pharmaceutical Co., Ltd.24 Apr 2026Human DrugsOn file
Jiangsu Willing Bio-tech Co., Ltd.27 Mar 2026Animal Drugs & FeedsOn file
Henan Lihua Pharmaceutical Co., Ltd.13 Feb 2026Human DrugsOn file
Fujian Genohope Biotech Ltd16 Jan 2026Human DrugsOn file
Hubei Gedian Humanwell Pharmaceutical Co., Ltd (Huanggang Site)19 Nov 2025Human DrugsOn file

Sites inspected

Zhejiang Huahai Pharmaceutical Co., Ltd.Linhai, China1 insp.
Jiangsu Willing Bio-tech Co., Ltd.Huai'An, China1 insp.
Henan Lihua Pharmaceutical Co., Ltd.Anyang, China1 insp.
Fujian Genohope Biotech LtdFutian, China1 insp.
Hubei Gedian Humanwell Pharmaceutical Co., Ltd (Huanggang Site)Huanggang, China1 insp.

Co-investigators

Investigators who share inspections with this person.

Peter E Baker10 shared
Yvins Dezan3 shared
Bapu R Gaddam3 shared
Atul Agrawal3 shared
Daniel J Roberts3 shared

Full investigator report

Get the verbatim findings behind Dipesh K Shah's 368 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators